Welcome to SeaLife Pharma

Sealife Pharma GmbH is an innovative drug development company focused on delivering new
first in class antibiotics derived from the chemical diversity of marine fungi (also known as
microbes or bugs from the sea).


Sealife has fully equipped synthetic and analytical chemistry as well as microbial and cell biology laboratories and is based in Austria at the Technopark 1, Tulln.

Besides developing novel antibiotics to fight multi-drug resistant infections, Sealife also provides CRO
services to the pharmaceutical sector.







SeaLife Pharma becomes partner in EU funded PharmaSea Project

Sealife is pleased to announce that it has become a partner in the PharmaSea project funded by the European Union under its FP7 program. This project focuses on bio-discovery research, development and commercialization of new substances from marine organisms. Its primary goal is to collect marine samples ...

Gefährliche Keime in Spitälern – Forscher in Tulln entwickeln wirksamere Antibiotika

Sie sind der Schrecken aller Mediziner: Krankheitskeime, die gengen herkömmliche Antibiotika "immun" sind. Forscher in Tulln haben jetzt Präparate entwickelt, die es sogar mit diesen aggressiven Erregern aufnehmen ...

First success with new antibiotic class from under the sea

Biotech startup SeaLife registered first promising results with their drug against multi-resistant bacteria. Components discovered in the sea, the novel antibiotic class (SLP0905) was tested in laboratory and proved effective against dangerous pathogens such as MRSA, Streptococcus or Enterococci...